Yasuhito Nannya1, June Takeda1, Shinya Sato2, Lanying Zhao1, Yusuke Shiozawa1,3, Yuichi Shiraishi4, Kenichi Chiba4, Hiroko Tanaka4, Masashi Sanada5, Nobuhiko Nakamura6, Hisashi Tsurumi6, Yuhei Shibata6,7, Senji Kasahara7, Rena Kamijo8, Masataka Taguchi2,8, Hiroshi Handa9, Kensuke Usuki10, Akifumi Takaori-Kondo11, Shigeru Chiba12, Norio Asou13, Hitoshi Kiyoi14, Tomoki Naoe5, Hideki Makishima1, Kenichi Yoshida1, Satoru Miyano4, Yasushi Miyazaki2, Seishi Ogawa1 (1.Pathol. and Tumor Biol., Kyoto Univ., Kyoto, Japan, 2.Dep. of Hematol, Nagasaki Univ., Nagasaki, Japan, 3.Dep. of Pediatrics, Tokyo Univ., Tokyo, Japan, 4.Lab of DNA information Analysis,HGC, Univ of Tokyo, Tokyo, Japan., 5.Nagoya Medical Center, Nagoya, Japan, 6.Dep. of Hematol., Gifu University, Gifu, Japan, 7.Dep. of Hematol., Gifu Municipal Hospital, Gifu, Japan, 8.Dep. of Hematol., Sasebo City General Hospital, Nagasaki, Japan, 9.Dep. of Hematol., Gunma University, Gunma, Japan, 10.Dep. of Hematol., NTT Medical Center, Tokyo, Japan, 11.Dep. of Hematol., Kyoto University, Kyoto, Japan, 12.Dep. of Hematol., Univ. of Tsukuba, Ibaraki, Japan, 13.Dep. of Hematol, Saitama Medical Univ IMC, Hidaka, Japan, 14.Dep. of Hematol, Nagoya Univ, Nagoya, Japan, 15.Dep. of Hematol, Kanazawa Univ, Kanazawa, Japan, 16.Dep. of Hematol, Tokyo Medical University, Tokyo, Japan)
Session information
Oral Session
Oral Session 3-5C MDS: Basic/Clinical
Sun. Oct 14, 2018 1:50 PM - 2:50 PM No.5 (Osaka International Convention Center, 12F Grand Toque)
Chair: Yuka Harada (Bunkyo Gakuin University, Japan)
Junichiro Yuda1,2, Kohta Itahashi2, Yosuke Togashi2, Nobuhiko Yamauchi1, Yosuke Minami1, Hiroyoshi Nishikawa2 (1.Department of Hematology National Cancer Center Hospital East, 2.Division of Cancer Immunology, Research Institute, National Cancer Center)
Rurika Okuda1, Hideki Makishima1, Tetsuichi Yoshizato1, Yasuhito Nannya1, Yasunobu Nagata1, June Takeda1, Kenichi Yoshida1, Masashi Sanada1,3, Yuichi Shiraishi4, Satoru Miyano5,6, Wolfgang Kern2, Constance R. Baer2, Niroshan Nadarajah2, Tamara Alpermann2, Claudia Haferlach2, Senji Kasahara7, Hiroshi Handa8, Shigeru Chiba6, Torsten Haferlach2, Seishi Ogawa1 (1.Pathol. and Tumor Biol., Kyoto Univ., Kyoto, Japan, 2.MLL Munich Leukemia Laboratory, Munich, Germany, 3.Nagoya Medical Center, Nagoya,, Japan, 4.Laboratory of Sequence Data Analysis, Human Genome Center, 5.Lab of DNA information Analysis,HGC, Univ of Tokyo, Tokyo, Japan., 6.Dep. of Hematol., Univ. of Tsukuba, Ibaraki, Japan, 7.Dep. of Hematol., Gifu Municipal Hospital, Gifu, Japan, 8.Dep. of Hematol., Gunma University, Gunma, Japan)
Naoki Shingai1, Hironori Harada2, Yuka Harada3, Hiroko Iizuka1, Soji Morishita4, Marito Araki4, Akimichi Ohsaka4, Noriko Doki5, Kazuteru Ohashi5, Masao Hagihara6, Norio Komatsu1 (1.Hematol., Juntendo Univ., Tokyo, Japan, 2.Oncology, Med. Sci., Tokyo Univ. Pharm. Life Sci., Tokyo, Japan, 3.Health Care Sci., Bunkyo Gakuin Univ. Grad. Sch., Tokyo, Japan, 4.Transfus. Med. & Stem Cell Rg., Juntendo Univ., Tokyo, Japan, 5.Cancer Infect. Dis. Cntr. Komagome Hosp., Tokyo, Japan, 6.Hematol., Eiju General Hosp., Tokyo, Japan)
[OS3-5C-5] Clinical features and the impact of gene abnormalities in chronic myelomonocytic leukemia
Shintaro Takiguchi1, Naoki Shingai2, Riko Shimomura1, Yosuke Ogata1, Noriko Doki3, Kazuteru Ohashi3, Masao Hagihara4, Norio Komatsu2, Yuka Harada1,3, Hironori Harada5 (1.Health Care Sci., Bunkyo Gakuin Univ. Grad. Sch., Tokyo, Japan, 2.Hematol., Juntendo Univ., Tokyo, Japan, 3.Cancer Infect. Dis. Cntr. Komagome Hosp., Tokyo, Japan, 4.Hematol., Eiju General Hosp., Tokyo, Japan, 5.Oncology, Med. Sci., Tokyo Univ. Pharm. Life Sci., Tokyo, Japan)
Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center)